Mucinex Fast-Max & NightShift Combo Pack - Max Strength Cough & Cold Medicines

Maximum Strength Mucinex Fast-Max Severe Congestion & Cough and Mucinex NightShift Cold & Flu are multi-symptom relief medicines designed to address both day and night cold symptoms. The day-time liquid helps relieve nasal and chest congestion, controls cough, and thins and loosens mucus. The night-time liquid, on the other hand, helps reduce fever, relieve headache, minor aches and pains, sore throat, coughing, sneezing, and runny nose, allowing for a better morning.

This product comes in a total of 12 FL OZ (2x6 FL OZ bottles) and is suitable for use by adults and children 12 years of age and over.

The day-time active ingredients include Dextromethorphan HBr (cough suppressant), Guaifenesin (expectorant), and Phenylephrine HCI (nasal decongestant). The night-time active ingredients consist of Acetaminophen (pain reliever and fever reducer), Dextromethorphan HBr (cough suppressant), and Triprolidine HCl (antihistamine).

It is important to note that Mucinex Fast-Max Severe Congestion & Cough and Mucinex Nightshift Cold & Flu should not be taken simultaneously. Users should always wait at least 4 hours before taking another dose of Mucinex liquid and should follow the directions for use.

Mucinex is the #1 Cough & Cold Brand that doctors trust and the #1 Pharmacist Recommended OTC Expectorant*. This combo pack provides powerful multi-symptom relief for the worst cold and flu symptoms, making it a trusted brand for adults.

Additionally, this product is FSA and HSA eligible, allowing users to save up to 30% by covering out-of-pocket expenses with pre-tax dollars. However, it is important to check with your benefits administrator to determine which expenses are eligible before making a purchase.

In summary, Maximum Strength Mucinex Fast-Max Severe Congestion & Cough and Mucinex NightShift Cold & Flu offer comprehensive relief for both day and night cold symptoms, providing a trusted and convenient solution for adults and children 12 years and older.

IQVIA using ProVoice Survey, August 2023 *U.S. News & World Report/Pharmacy Times 2023-2024

product information: